Cargando…

The association of vancomycin trough levels with outcomes among patients with methicillin-resistant Staphylococcus aureus (MRSA) infections: Retrospective cohort study

INTRODUCTION: Current guidelines recommend maintaining vancomycin trough concentrations between 15–20 mg/L for serious methicillin resistant staphylococcus aureus (MRSA) infections. This recommendation is based on limited evidence. METHODS: A retrospective study including patients with vancomycin su...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yahav, Dafna, Abbas, Maria, Nassar, Laila, Ghrayeb, Alia, Kurnik, Daniel, Shepshelovich, Daniel, Leibovici, Leonard, Paul, Mical
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6448937/ https://www.ncbi.nlm.nih.gov/pubmed/30946754 http://dx.doi.org/10.1371/journal.pone.0214309

Ejemplares similares

Trimethoprim-sulfamethoxazole versus vancomycin for severe infections caused by meticillin resistant Staphylococcus aureus: randomised controlled trial
por: Paul, Mical, et al.
Publicado: (2015)

External validity of a randomised controlled trial on the treatment of severe infections caused by MRSA
por: Paul, Mical, et al.
Publicado: (2015)

Co-trimoxazole–Sensitive, Methicillin-Resistant Staphylococcus aureus, Israel, 1988–1997
por: Bishara, Jihad, et al.
Publicado: (2003)

Impact of Initial Vancomycin Trough Concentration on Clinical and Microbiological Outcomes of Methicillin-Resistant Staphylococcus aureus Bacteremia in Children
por: Yoo, Ree Nar, et al.
Publicado: (2017)

A Rare Case of Methicillin-Resistant Staphylococcus aureus (MRSA) Enterocolitis Treated With Oral Vancomycin
por: Tagliaferri, Ariana R, et al.
Publicado: (2021)

Nosocomial methicillin-resistant staphylococcus aureus (MRSA) pneumonia: linezolid or vancomycin? - Comparison of pharmacology and clinical efficacy
por: Pletz, Mathias W, et al.
Publicado: (2010)

Combination Vancomycin/Cefazolin (VAN/CFZ) for Methicillin-Resistant Staphylococcus aureus (MRSA) Bloodstream Infections (BSI)
por: Trinh, Trang D, et al.
Publicado: (2017)

192 Vancomycin Dosing in Obese and Morbidly Obese Patients with Methicillin-Resistant Staphylococcus aureus (MRSA) Pneumonia
por: Morrill, Haley, et al.
Publicado: (2014)

Effects of topical Vancomycin Dressing on Methicillin-Resistant Staphylococcus Aureus (MRSA) positive diabetic foot ulcers
por: Saif, Anas Bin, et al.
Publicado: (2019)

Association of mprF mutations with cross-resistance to daptomycin and vancomycin in methicillin-resistant Staphylococcus aureus (MRSA)
por: Thitiananpakorn, Kanate, et al.
Publicado: (2020)

2003. Vancomycin Discontinuation Is Supported by-negative Nasal Methicillin-Resistant Staphylococcus aureus (MRSA) in Patients with Pneumonia
por: Pleasants, Katherine A, et al.
Publicado: (2019)

Vancomycin (VAN) Combinations with Β-Lactams (BLs) against Methicillin-Resistant Staphylococcus aureus (MRSA), Heterogeneous Intermediate-Level Resistance to Vancomycin (hVISA) and Vancomycin-Intermediate Staphylococcus aureus (VISA)
por: Tran, Kieu-Nhi, et al.
Publicado: (2017)

Daptomycin susceptibility of methicillin resistant Staphylococcus aureus (MRSA)
por: Kaur, Rajneet, et al.
Publicado: (2012)

Prevalence of vancomycin resistant Staphylococcus aureus (VRSA) in methicillin resistant S. aureus (MRSA) strains isolated from burn wound infections
por: Hasan, Rashedul, et al.
Publicado: (2016)

Evaluation of the Combined Effects of Stilbenoid from Shorea gibbosa and Vancomycin against Methicillin-Resistant Staphylococcus aureus (MRSA)
por: Basri, Dayang Fredalina, et al.
Publicado: (2012)

78. Impact of Methicillin-Resistant Staphylococcus aureus (MRSA) Nares Screen on Vancomycin Utilization for Respiratory Tract Infections
por: Debnath, Ashita, et al.
Publicado: (2021)

Vancomycin Heteroresistance in Methicillin-resistant Staphylococcus aureus, Taiwan
por: Wang, Jiun-Ling, et al.
Publicado: (2004)

Methicillin-Susceptible, Vancomycin-Resistant Staphylococcus aureus, Brazil
por: Panesso, Diana, et al.
Publicado: (2015)

Natural history of colonization with methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE): a systematic review
por: Shenoy, Erica S, et al.
Publicado: (2014)

1596. Impact of Vancomycin Area Under Curve on Persistent Methicillin-Resistant Staphylococcus aureus (MRSA) Bloodstream Infections (BSI)
por: Alosaimy, Sara, et al.
Publicado: (2019)

Methicillin-Resistant Staphylococcus aureus (MRSA) in Artisanal Cheeses in México
por: Adame-Gómez, Roberto, et al.
Publicado: (2018)

The ratio of pre-dialysis vancomycin trough serum concentration to minimum inhibitory concentration is associated with treatment outcomes in methicillin-resistant Staphylococcus aureus bacteremia
por: Fu, Chien-Fang, et al.
Publicado: (2018)

721 Decreasing Prevalence of Vancomycin-Heteroresistance (hVISA) among Methicillin-Resistant Staphylococcus aureus (MRSA) Blood Isolates over 10 years: Potential Impact of Vancomycin Treatment Guidelines
por: Khatib, Riad, et al.
Publicado: (2014)

Dalbavancin reduces biofilms of methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-resistant Staphylococcus epidermidis (MRSE)
por: Knafl, D., et al.
Publicado: (2016)

In vitro transfer of methicillin resistance determinants mecA from methicillin resistant Staphylococcus aureus (MRSA) to methicillin susceptible Staphylococcus aureus (MSSA)
por: Bitrus, Asinamai Athliamai, et al.
Publicado: (2017)

Antibacterial potential of Malaysian ethnomedicinal plants against methicillin-susceptible Staphylococcus aureus (MSSA) and methicillin-resistant Staphylococcus aureus (MRSA)
por: Yi Xin, Low, et al.
Publicado: (2021)

Cost Analysis of New Antibiotics to Treat Multidrug-Resistant Bacterial Infections: Mind the Gap
por: Yahav, Dafna, et al.
Publicado: (2021)

The safety and efficacy of high versus low vancomycin trough levels in the treatment of patients with infections caused by methicillin-resistant Staphylococcus aureus: a meta-analysis
por: Tongsai, Sasima, et al.
Publicado: (2016)

Vancomycin Susceptibility within Methicillin-resistant Staphylococcus aureus Lineages
por: Howe, Robin A., et al.
Publicado: (2004)

Methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility in Taiwan
por: Lin, Chien-Yu, et al.
Publicado: (2018)

Resistance and Molecular Characteristics of Methicillin-Resistant Staphylococcus aureus and Heterogeneous Vancomycin-Intermediate Staphylococcus aureus
por: Liang, Jin, et al.
Publicado: (2023)

Hospital-associated methicillin-resistant Staphylococcus aureus (HA-MRSA) in Italy
por: Campanile, Floriana, et al.
Publicado: (2009)

Methicillin-resistant staphylococcus aureus (MRSA) carriage in a dermatology unit
por: Pacheco, Renata L., et al.
Publicado: (2011)

Misidentification of methicillin-resistant Staphylococcus aureus (MRSA) in hospitals in Tripoli, Libya
por: Ahmed, Mohamed O., et al.
Publicado: (2010)

Methicillin resistant Staphylococcus aureus (MRSA) in India: Prevalence & susceptibility pattern
por: Joshi, Sangeeta, et al.
Publicado: (2013)

Prevalence of methicillin-resistant Staphylococcus aureus (MRSA) in retail food in Singapore
por: Aung, Kyaw Thu, et al.
Publicado: (2017)

New combination approaches to combat methicillin-resistant Staphylococcus aureus (MRSA)
por: Sharaf, Mohamed H., et al.
Publicado: (2021)

Drivers of methicillin-resistant Staphylococcus aureus (MRSA) lineage replacement in China
por: Chen, Hongbin, et al.
Publicado: (2021)

The antibacterial mechanism of oridonin against methicillin-resistant Staphylococcus aureus (MRSA)
por: Yuan, Zhongwei, et al.
Publicado: (2019)

Effectiveness of Daptomycin in Patients with Persistent Methicillin-Resistant Staphylococcus aureus Bacteremia Despite Vancomycin
por: Kale-Pradhan, Pramodini, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_f058h9ekdded2bs39ah9m0a215